The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income (loss) attributable to parent | -3,521 | -2,904 | -9,246 | - |
| Amortization of deferred financing costs | 6 | 0 | 18 | - |
| Change in fair value of convertible notes (issued, converted and outstanding) | - | 0 | 0 | - |
| Change in fair value of liability classified warrants | 0 | 0 | 0 | -32 |
| Shares issued for the standby equity purchase agreement commitment fee | - | 0 | 298 | - |
| Stock-based compensation | 91 | 70 | 290 | 264 |
| Change in fair value of convertible notes (issued, converted and outstanding) | - | - | - | 0 |
| Accounts receivables | -58 | 16 | 4 | 105 |
| Net loss | - | - | - | -5,774 |
| Inventory | -9 | -17 | 6 | 77 |
| Prepaid expenses | -117 | 490 | -244 | -784 |
| Other liabilities | - | 0 | 0 | 0 |
| Other assets | -79 | -78 | -80 | -156 |
| Shares issued for the standby equity purchase agreement commitment fee | - | - | - | 298 |
| Accounts payable | -229 | -1,070 | -1,140 | 112 |
| Amortization of deferred financing costs | - | - | - | 18 |
| Accrued expenses | 629 | 221 | 164 | -1,305 |
| Net cash used in operating activities | -2,761 | -4,094 | -3,844 | -5,661 |
| Proceeds from issuance of convertible notes | - | 0 | 0 | 0 |
| Payment of convertible notes | - | 0 | 0 | 0 |
| Proceeds from issuance of shares, net of offering costs | 329 | 1,789 | 9,183 | 5,154 |
| Proceeds from exercise warrants-Convertible Note Warrants | - | - | 1,818 | - |
| Proceeds from exercise warrants | 0 | 1,813 | - | 2 |
| Proceeds of pre-funded warrants | 0 | 0 | 5,886 | - |
| Proceeds from issuance of notes payable | - | 767 | - | - |
| Proceeds of pre-funded warrants | - | - | - | 5,580 |
| Payment of notes payable | 200 | 242 | 0 | 592 |
| Net cash provided by financing activities | 129 | 2,311 | 11,305 | 10,144 |
| Net increase (decrease) in cash | -2,632 | -1,783 | 11,944 | - |
| Cash, beginning of period | 11,980 | 13,763 | 1,819 | - |
| Net increase in cash | - | - | - | 4,483 |
| Cash, end of period | 9,348 | 11,980 | 13,763 | - |
SeaStar Medical Holding Corp (ICUCW)
SeaStar Medical Holding Corp (ICUCW)